Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Prázný

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Vnitrni Lekarstvi|April 16, 2015
[Mild hypoglycaemia is common in type 2 diabetic patients treated with insulin analogues in the Czech Republic and the patients are concerned about it: results of a GAPP2TM survey (Global Attitudes of Physicians and Patient)]Martin Prázný
Vnitrni Lekarstvi|October 8, 2022
The position of SGLT2 inhibitors in current medical practice - update 2022Martin Prázný
Vnitrni Lekarstvi|September 18, 2020
The position of SGLT2 inhibitors in current medicineMartin Prázný
Vnitrni Lekarstvi|April 21, 2015
[Progress in the development of insulin pumps and their advanced automatic functions]Martin Prázný
Vnitrni Lekarstvi|January 21, 2015
[Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic]Martin Prázný
Vnitrni Lekarstvi|April 21, 2015
[The position of new antidiabetics in clinical practice: SGLT2 vs DPP4 inhibitors]Jan Šoupal, Martin Prázný
Vnitrni Lekarstvi|October 9, 2014
[Glycemic variability and continuous monitoring of glycemia]Martin Prázný, Jan Soupal
Vnitrni Lekarstvi|August 4, 2016
[Insulin application techniques in adult patients with diabetes]Tomáš Pelcl, Martin Prázný
Vnitrni Lekarstvi|March 28, 2015
[Empagliflozin - the new representative of SGLT2 transporter inhibitors for the treatment of patients with diabetes 2 type]Martin Prázný, Jiří Slíva
Vnitrni Lekarstvi|October 9, 2014
[Gliptins: a safe and effective treatment of diabetes mellitus]Jiří Slíva, Martin Prázný
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Vnitrni Lekarstvi|April 16, 2015
[Mild hypoglycaemia is common in type 2 diabetic patients treated with insulin analogues in the Czech Republic and the patients are concerned about it: results of a GAPP2TM survey (Global Attitudes of Physicians and Patient)]Martin Prázný
Vnitrni Lekarstvi|October 8, 2022
The position of SGLT2 inhibitors in current medical practice - update 2022Martin Prázný
Vnitrni Lekarstvi|September 18, 2020
The position of SGLT2 inhibitors in current medicineMartin Prázný
Vnitrni Lekarstvi|April 21, 2015
[Progress in the development of insulin pumps and their advanced automatic functions]Martin Prázný
Vnitrni Lekarstvi|January 21, 2015
[Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic]Martin Prázný
Vnitrni Lekarstvi|April 21, 2015
[The position of new antidiabetics in clinical practice: SGLT2 vs DPP4 inhibitors]Jan Šoupal, Martin Prázný
Vnitrni Lekarstvi|October 9, 2014
[Glycemic variability and continuous monitoring of glycemia]Martin Prázný, Jan Soupal
Vnitrni Lekarstvi|August 4, 2016
[Insulin application techniques in adult patients with diabetes]Tomáš Pelcl, Martin Prázný
Vnitrni Lekarstvi|March 28, 2015
[Empagliflozin - the new representative of SGLT2 transporter inhibitors for the treatment of patients with diabetes 2 type]Martin Prázný, Jiří Slíva
Vnitrni Lekarstvi|October 9, 2014
[Gliptins: a safe and effective treatment of diabetes mellitus]Jiří Slíva, Martin Prázný
Pageof 5